drugset / Trial / NCT03997864

Administration of Prazosin to Prevent PTSD in Adult Women After Sexual Assault

NCT03997864

Phase 4 Withdrawn University of Colorado, Denver
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study plans to learn more about whether taking the medication, Prazosin, immediately and during the weeks immediately following a traumatic event can help to reduce the risk of developing posttraumatic stress disorder (PTSD). Early post traumatic event sleep disturbance predicts the later development of PTSD. Prazosin has shown some effectiveness in reducing trauma related nightmares and sleep disturbance. We hypothesize that regulating sleep immediately after a sexual assault will reduce PTSD and diminish symptoms.

Timeline

Start
2020-02-23
Primary completion
2021-08-20
Completion
2021-08-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prazosin Unknown 15 mg